Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis
Open Access
- 3 September 2002
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (5) , 279-285
- https://doi.org/10.1038/sj.bmt.1703627
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosisBone Marrow Transplantation, 2001
- Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantationBone Marrow Transplantation, 2001
- Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)Bone Marrow Transplantation, 2000
- Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status reportBone Marrow Transplantation, 2000
- Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpuraBone Marrow Transplantation, 1999
- Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell supportBone Marrow Transplantation, 1999
- Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsBritish Journal of Haematology, 1998
- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and ColchicineNew England Journal of Medicine, 1997
- Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine onlyThe American Journal of Medicine, 1996
- Intensive Therapy in AL Amyloidosis and Light-Chain Deposition DiseaseAnnals of Internal Medicine, 1995